International Journal of Oncology

MUTATIONS OF RAS GENES IN HUMAN TUMORS (REVIEW)
pp. 413-421(9)
Authors: KIARIS, H; SPANDIDOS, DA

TELOMERES AND TELOMERASE IN HUMAN CANCER (REVIEW)
pp. 423-432(10)
Authors: BACCHETTI, S; COUNTER, CM

INDUCTION OF APOPTOSIS BY RETINOIDS IN HUMAN CERVICAL-CARCINOMA CELL-LINES
pp. 433-441(9)
Authors: ORIDATE, N; LOTAN, D; MITCHELL, MF; HONG, WK; LOTAN, R

IN-VIVO AND IN-VITRO ANALYSIS OF RETROVIRAL VECTORS CARRYING THE N-RAS ONCOGENE
pp. 443-451(9)
Authors: MATESANZ, F; PELLICER, A

SUPPRESSION AND RESTORATION OF V-SRC EXPRESSION IN RSV TRANSFORMED-CELLS AFTER TRANSFECTION WITH N-RAS AND ITS ANTAGONIST
pp. 453-459(7)
Authors: TCHEVKINA, EM; KISSELJOVA, NP; SHTUTMAN, MS; MUSATKINA, EA; MIZENINA, OA; LESKOV, KV; TAVITIAN, A; KISSELJOV, FL

TUMOR-NECROSIS-FACTOR AND DNA TOPOISOMERASE-II INHIBITORS IN HUMAN OVARIAN-CANCER - POTENTIAL ROLE IN CHEMOTHERAPY
pp. 461-467(7)
Authors: ALUIGI, MG; DEBERNARDIS, D; CIMOLI, G; OTTOBONI, C; PARODI, S; RUSSO, P

INCREASED EXPRESSION OF GELATINASE-A AND TIMP-2 IN PRIMARY HUMAN GLIOBLASTOMAS
pp. 469-473(5)
Authors: SAXENA, A; ROBERTSON, JT; KUFTA, C; STETLERSTEVENSON, WG; ALI, IU

DIFLOXACIN REVERSES MULTIDRUG-RESISTANCE IN P388 ADR CELLS VIA A MECHANISM INDEPENDENT OF P-GLYCOPROTEIN AND WITHOUT CORRECTING DRUG TRANSPORT OR SUBCELLULAR DRUG DISTRIBUTION
pp. 475-480(6)
Authors: GUPTA, S; THADEPALLI, F; GOLLAPUDI, S

INHIBIN ACTIVIN SUBUNITS AND ACTIVIN RECEPTORS IN HUMAN BREAST CELL-LINES AND LACTATING RAT MAMMARY-GLANDS
pp. 481-485(5)
Authors: YING, SY; ZHANG, Z; HUANG, G; HSIEH, FC

COOPERATIVE INHIBITORY EFFECT OF N,N,N-TRIMETHYLSPHINGOSINE AND SPHINGOSINE-1-PHOSPHATE, CO-INCORPORATED IN LIPOSOMES, ON B16 MELANOMA CELL METASTASIS - CELL-MEMBRANE SIGNALING AS A TARGET IN CANCER-THERAPY .4.
pp. 487-494(8)
Authors: PARK, YS; RUAN, FQ; HAKOMORI, SI; IGARASHI, Y

NONRANDOM SECONDARY CHROMOSOME-ABERRATIONS IN SYNOVIAL SARCOMAS WITH T(X-18)
pp. 495-499(5)
Authors: MANDAHL, N; LIMON, J; MERTENS, F; NEDOSZYTKO, B; GIBAS, Z; DENIS, A; WILLEN, H; RYDHOLM, A; SZADOWSKA, A; KREICBERGS, A; RYS, J; DEBIECRYCHTER, M; MITELMAN, F

IFN-GAMMA AND B7 AS COSTIMULATORS OF ANTITUMOR IMMUNE-RESPONSES
pp. 501-509(9)
Authors: FLORES, I; SARKAR, S; DEROSA, C; OZZELLO, L; NABAVI, N; SHEN, YR; RON, Y; PESTKA, S

DETECTION OF K-RAS MUTATIONS IN NONSMALL CELL LUNG-CARCINOMA
pp. 511-514(4)
Authors: NEVILLE, EM; ELLISON, G; KIARIS, H; STEWART, M; SPANDIDOS, DA; FOX, JC; FIELD, JK

THE HSV-2 LA-1 ONCOPROTEIN IS A MEMBER OF A NOVEL FAMILY OF SERINE THREONINE RECEPTOR KINASES
pp. 515-522(8)
Authors: HUNTER, JCR; SMITH, CC; AURELIAN, L

IFN-ALPHA THERAPY OF RENAL-CELL CARCINOMA - DEFECT OF LYMPHOCYTE SENSITIVITY TO MITOGENIC AND ACTIVATING CYTOKINE SIGNALS IN PATIENTS NOT-RESPONDING TO THERAPY
pp. 523-526(4)
Authors: INDROVA, M; BUBENIK, J; JAKOUBKOVA, J; SOBOTA, V; HELMICHOVA, E; SIMOVA, J

DIFFERENTIAL REGULATION BY ESTROGEN OF C-FOS IN HAMSTER-KIDNEY AND ESTROGEN-INDUCED KIDNEY TUMOR-CELLS - RECEPTOR MEDIATION VS METABOLIC-ACTIVATION
pp. 527-534(8)
Authors: BHAT, HK; HACKER, HJ; THOMPSON, EB; LIEHR, JG

DIFFERENTIAL EXPRESSION OF NEU MESSENGER-RNA AND PROTEIN IN HAMSTER-KIDNEY AND ESTROGEN-INDUCED KIDNEY TUMORS
pp. 535-538(4)
Authors: BHAT, HK; SPRINGER, I; RAJARAMAN, S; LIEHR, JG

ADHESIVE FUNCTION OF NEWCASTLE-DISEASE VIRUS HEMAGGLUTININ IN TUMOR-HOST INTERACTION
pp. 539-545(7)
Authors: JURIANZ, K; HAAS, C; HUBBE, M; ERTEL, C; BRUNNER, G; ALTEVOGT, P; SCHIRRMACHER, V; VONHOEGEN, P

NUCLEOTIDE-METABOLISM AND CHROMOSOME ALTERATIONS IN HUMAN-MALIGNANT MELANOMA XENOGRAFTS
pp. 547-554(8)
Authors: BARDOT, V; LUCCIONI, C; DUTRILLAUX, AM; BLANCHO, D; BEAUMATIN, J; DUTRILLAUX, B

ESTABLISHMENT OF MYELOID PROGENITOR LINES FROM PRIMARY CULTURES OF MURINE BONE-MARROW CELLS EXPRESSING A V-MYB ONCOPROTEIN
pp. 555-563(9)
Authors: DELANUX, VM; REIS, MD; HAWLEY, RG

PKC-DEPENDENT AND PKC-INDEPENDENT CELLULAR EFFECTS INDUCED BY RECOMBINANT TRANSFORMING GROWTH-FACTOR TYPE-BETA-1
pp. 565-572(8)
Authors: STRAUSS, SC; WEBER, M; SCHACHTELE, C; BAUER, G

AUTOCRINE GROWTH-FACTOR SECRETION AFTER TRANSFORMATION OF HUMAN CYTOKINE-DEPENDENT CELLS BY VIRAL AND CELLULAR ONCOGENES
pp. 573-586(14)
Authors: MCCUBREY, JA; STEELMAN, LS; WANG, XY; DAVIDIAN, EW; HOYLE, PE; WHITE, CR; PREVOST, KD; ALGATE, PA; ROBBINS, P; MYLOTT, D; WHITE, MK

ALTERATIONS OF THE APC GENE IN CARCINOMA CELL-LINES AND PRECANCEROUS LESIONS OF THE STOMACH
pp. 587-592(6)
Authors: NISHIMURA, K; YOKOZAKI, H; HARUMA, K; KAJIYAMA, G; TAHARA, E

EFFECTS OF CISPLATIN AND MAFOSFAMIDE ON THE INTERPHASE MICROTUBULAR CYTOSKELETON OF A HUMAN BREAST-CANCER CELL-LINE, MX-1, IN-VITRO - A FINE-STRUCTURE AND ANTITUBULIN IMMUNOFLUORESCENCE STUDY
pp. 593-602(10)
Authors: WOLF, KW; MENDOZA, AS; MENTZEL, M; WOSSMANN, W; JOSHI, HC

ON THE USE OF SYRIAN-HAMSTER CELL-CULTURES AS TARGETS FOR CARCINOGEN-SCREENING
pp. 603-609(7)
Authors: IYPE, PT; KUMARI, HL; KAIGHN, ME; HUKKU, B

DIRECT ISOLATION OF VARIABLY AMPLIFIED CDNAS FROM HUMAN TUMOR-CELL LINES
pp. 611-615(5)
Author: LIANG, BC

AMPHIREGULIN AND CRIPTO OVEREXPRESSION IN BREAST-CANCER - RELATIONSHIP WITH PROGNOSIS AND CLINICAL AND MOLECULAR-VARIABLES
pp. 617-622(6)
Authors: DUBLIN, EA; BOBROW, LG; BARNES, DM; GULLICK, WJ

TUMORIGENICITY ASSOCIATED WITH CHROMOSOME 11P15 ALTERATIONS IN SV40-TRANSFORMED HUMAN KIDNEY-CELLS
pp. 623-630(8)
Authors: POIRIER, V; TYLER, SJ; SLEEMAN, J; DIFFIN, F; BROWN, KW

PROGNOSTIC-SIGNIFICANCE OF CHROMOSOME 5Q AND 17P ALLELIC DELETION IN COLORECTAL ADENOCARCINOMAS
pp. 631-635(5)
Authors: KHINE, K; GOH, HS; SMITH, DR

RAPID KILLING OF UROTHELIAL CARCINOMA-CELLS BY WILD-TYPE P53
pp. 637-641(5)
Authors: MAKRI, D; SCHULZ, WA; GRIMM, MO; SCHMITZDRAGER, BJ

POTENTIATION OF THE MITOGENIC EFFECT OF ESTROGEN ON THE PITUITARY-GLAND BY ALCOHOL-CONSUMPTION
pp. 643-648(6)
Authors: DE, A; BOYADJIEVA, N; PASTORCIC, MG; SARKAR, DK

PARTIAL CHARACTERIZATION OF A CISPLATIN-RESISTANT SUBLINE OF MURINE RIF-1 TUMOR-CELLS
pp. 649-656(8)
Authors: MANSOURI, A; HENLE, KJ; NAGLE, WA; PARKER, RJ; REED, E

PRODUCTION OF TGF-BETA AND HGF RECEPTOR BY A DIFFERENTIATED PAPILLARY THYROID-CARCINOMA CELL-LINE (B-CPAP) - IMPLICATION IN MALIGNANCY
pp. 657-660(4)
Authors: PAULIN, C; AVALLET, O; TARDY, F; SAEZ, J; FUSCO, A; FABIEN, N

JUVENILE GRANULOSA-CELL TUMOR OF THE OVARY - INTERPHASE CYTOGENETICS FOR CHROMOSOME-12 AND CHROMOSOME-X AND FLOW CYTOMETRIC DNA-PLOIDY STUDY
pp. 661-665(5)
Authors: KEMP, BL; SILVA, EG; ELNAGGAR, AK

DIFFERENTIAL-EFFECTS OF OMEGA-3 AND OMEGA-6 FATTY-ACIDS ON PRIMARY TUMOR-GROWTH AND METASTASIS
pp. 667-672(6)
Authors: TOROSIAN, MH; CHARLAND, SL; LAPPIN, JA

NUCLEAR MORPHOMETRY FOR PREDICTING CERVICAL METASTATIC POTENTIAL IN LARYNGEAL SQUAMOUS-CELL CARCINOMA
pp. 673-677(5)
Authors: DONAT, TL; SAKR, W; PIENTA, KJ

HISTOLOGIC CHARACTERISTICS OF RESIDUAL RENAL-CELL CARCINOMA FOLLOWING INTERFERON-ALPHA-BASED THERAPY - CORRELATION WITH CLINICAL-PARAMETERS
pp. 679-684(6)
Authors: SHIN, HJC; RO, JY; SELLA, A; AMIN, M; ORDONEZ, NG; AYALA, AG

INHIBITION OF PKC AND PKA BY CHEMOPREVENTIVE ORGANOSELENIUM COMPOUNDS
pp. 685-690(6)
Authors: FOILES, PG; FUJIKI, H; SUGANUMA, M; OKABE, S; YATSUNAMI, J; MIGLIETTA, LM; UPADHYAYA, P; ELBAYOUMY, K; RONAI, Z